FindTrial
Sign In

Concentration of Unbound Cloxacillin in Adults Treated with Continuous Infusion via Elastomeric Pump

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-510423-30-00
Enrollment
25
Registered
2025-07-25
Start date
2025-12-12
Completion date
Unknown
Last updated
2025-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Staphylococcus aureus infection

Brief summary

Concentration of total and free (unbound) cloxacillin at four time points; at the start of continuous infusion, 4h (±1h) after the start of continuous infusion, 24h (±1h) after the start of continuous infusion, and 48h (±1h) after the start of continuous infusion.

Interventions

DRUGCloxacillin Stragen 2 g pulver till injektions-/infusionsvätska
DRUGlösning

Sponsors

Region Vaestmanland
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Concentration of total and free (unbound) cloxacillin at four time points; at the start of continuous infusion, 4h (±1h) after the start of continuous infusion, 24h (±1h) after the start of continuous infusion, and 48h (±1h) after the start of continuous infusion.—

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026